RecruitingNCT06810310
Psilocybin and brain processes linked to motivation in opioid use
About this title
Read the official source — NCT06810310Medication studyAges 18–60United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 22, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- University of Pennsylvania
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06810310
- Official title
Show the full official title
Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pennsylvania, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin (high dose) and psilocybin (low dose).
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
